FAPI-46: Clinical Trials

3 trials of FAPI-46, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 recruiting. 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 23Recruiting 3

Follow FAPI-46: new trials by email Literature Review of FAPI-46 trials Research Report on FAPI-46

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Multimodal Imaging With FAPI-PET/MRI in Breast Carcinoma-In-Situ for Detection of Occult Invasive Cancer
[68Ga]Ga-FAPI-46 - Carcinoma, Intraductal, Noninfiltrating
Phase 2RecruitingUniversität Münster302026-02-202026-06-03
Cutting Edge Imaging With PET-FAPI for Earlier Pancreatic Cancer Diagnosis (INDIGO-FAPI)
68Ga-FAPI-46 for PET / CT scan - Pancreatic Ductal Adenocarcinoma (PDAC)
Phase 2RecruitingInstitut Curie352025-12-022026-04-15
Investigational Scan (68Ga-FAPI-46 PET/CT) for Imaging of Cancer-Associated Fibroblasts for Localized Pancreatic Ductal Adenocarcinoma
Computed Tomography, Gallium Ga 68 FAPi-46, Positron Emission Tomography - Localized Pancreatic Adenocarcinoma, Resectable Pancreatic Ductal Adenocarcinoma
Phase 2RecruitingMayo Clinic1302022-11-152026-08-10

Conditions studied

Breast Neoplasms (1)  ·  Carcinoma, Intraductal, Noninfiltrating (1)  ·  Pancreatic Neoplasms (1)

Sponsors

Institut Curie (1)  ·  Mayo Clinic (1)  ·  Universität Münster (1)

Countries

France (1)  ·  Germany (1)  ·  United States (1)

Top investigators

Ajit H. Goenka, M.D. (1)  ·  Nicolas Deleval (1)  ·  Philipp Backhaus, Dr. med. (1)

NIH funding

2023 (1), R01CA272628 (1)